EA200700735A1 - Капсулы лерканидипина - Google Patents

Капсулы лерканидипина

Info

Publication number
EA200700735A1
EA200700735A1 EA200700735A EA200700735A EA200700735A1 EA 200700735 A1 EA200700735 A1 EA 200700735A1 EA 200700735 A EA200700735 A EA 200700735A EA 200700735 A EA200700735 A EA 200700735A EA 200700735 A1 EA200700735 A1 EA 200700735A1
Authority
EA
Eurasian Patent Office
Prior art keywords
fatty acid
pharmaceutical composition
mixture
polyethylene glycol
modified release
Prior art date
Application number
EA200700735A
Other languages
English (en)
Inventor
Амедео Леонарди
Фабио Берлати
Лино Понтелло
Original Assignee
Рекордати Айерленд Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рекордати Айерленд Лимитед filed Critical Рекордати Айерленд Лимитед
Publication of EA200700735A1 publication Critical patent/EA200700735A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Фармацевтическая композиция с модифицированным высвобождением включает лерканидипин, растворенный в воскообразном веществе, содержащем жирно-кислотный эфир многоатомного спирта, при этом раствор содержится в фармацевтически приемлемой капсуле. Эфир жирной кислоты и многоатомного спирта предпочтительно является полиэтиленгликолевым эфиром, полипропиленгликолевым эфиром, глицеридом жирных кислот или смесью двух или нескольких указанных соединений. Эфир жирной кислоты и многоатомного спирта в наиболее предпочтительной форме является смесью моно-, ди- и триглицеридов и полиэтиленгликолевых моноэфиров и сложных диэфиров. Было обнаружено, что пероральный прием пациентом фармацевтической композиции с модифицированным высвобождением приводит к средней концентрации лерканидипина в плазме, превышающей 0,5 нг/мл, в течение 24 ч после приема.
EA200700735A 2004-10-05 2005-10-05 Капсулы лерканидипина EA200700735A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61591904P 2004-10-05 2004-10-05
US65679205P 2005-02-25 2005-02-25
PCT/EP2005/010813 WO2006037650A1 (en) 2004-10-05 2005-10-05 Lercanidipine capsules

Publications (1)

Publication Number Publication Date
EA200700735A1 true EA200700735A1 (ru) 2007-10-26

Family

ID=35455723

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700735A EA200700735A1 (ru) 2004-10-05 2005-10-05 Капсулы лерканидипина

Country Status (16)

Country Link
US (1) US20060073200A1 (ru)
EP (1) EP1807059A1 (ru)
JP (1) JP2008515839A (ru)
KR (1) KR20070058632A (ru)
AR (1) AR051742A1 (ru)
AU (1) AU2005291354A1 (ru)
BR (1) BRPI0516179A (ru)
CA (1) CA2580525A1 (ru)
EA (1) EA200700735A1 (ru)
IL (1) IL181938A0 (ru)
MX (1) MX2007004105A (ru)
NO (1) NO20072332L (ru)
PE (1) PE20060946A1 (ru)
TW (1) TW200616681A (ru)
UY (1) UY29150A1 (ru)
WO (1) WO2006037650A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
WO2008040367A1 (en) * 2006-08-01 2008-04-10 Union Quimico-Farmaceutica S.A. Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof
BRPI0716196A2 (pt) * 2006-08-31 2013-11-12 Eurand Inc Sistemas de distribuição de fármacos que compreendem soluções sólidas de fármacos fracamente básicos.
US20080175872A1 (en) * 2006-09-28 2008-07-24 Osmotica Corp. Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
DE102010005124A1 (de) * 2010-01-19 2012-03-01 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung umfassend Lercanidipin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
US5912351A (en) * 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
US5696139A (en) * 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
ES2191977T3 (es) * 1997-10-27 2003-09-16 Merck Patent Gmbh Soluciones y dispersiones en estado solido de farmacos poco solubles en agua.
US20030235595A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
US20030069285A1 (en) * 2001-08-06 2003-04-10 Recordati Ireland Limited Novel solvate and crystalline forms of lercanidipine hydrochloride
US6852737B2 (en) * 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride

Also Published As

Publication number Publication date
BRPI0516179A (pt) 2008-08-26
EP1807059A1 (en) 2007-07-18
AU2005291354A1 (en) 2006-04-13
NO20072332L (no) 2007-05-04
AR051742A1 (es) 2007-02-07
UY29150A1 (es) 2005-11-30
IL181938A0 (en) 2007-07-04
MX2007004105A (es) 2007-06-15
CA2580525A1 (en) 2006-04-13
WO2006037650A1 (en) 2006-04-13
KR20070058632A (ko) 2007-06-08
US20060073200A1 (en) 2006-04-06
JP2008515839A (ja) 2008-05-15
PE20060946A1 (es) 2006-10-02
TW200616681A (en) 2006-06-01

Similar Documents

Publication Publication Date Title
WO2002039983A3 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
ES2657813T3 (es) Composiciones farmacéuticas para calanolidas, sus derivados y análogos, y proceso para su producción
ES2540727T3 (es) Composición farmacéutica antimalárica
EA200700735A1 (ru) Капсулы лерканидипина
FR2737121A1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
PL318560A1 (en) Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
AU2010240653A1 (en) Sublingual pharmaceutical composition comprising a neutral oil
RU2002122744A (ru) Новая самоэмульгирующаяся система доставки лекарств
ATE301989T1 (de) Orale pharmazeutische zusammensetzung mit einem wirkstoff, der bei seiner ersten darmpassage starken wirkungen ausgesetzt werden kann
CA2137764C (en) Pharmaceutical compositions comprising solutions or dispersions of a staurosporine active ingredient in a saturated polyalkylene glycol glyceride
RU2017110076A (ru) Фармацевтическая композиция и способы
RU2004127237A (ru) Твердая препаративная форма с замедленным/контролируемым высвобождением как новая система доставки лекарственного средства со сниженным риском демпинга дозы
RU1829935C (ru) Способ получени флунаризинсодержащей композиции
JP5795760B2 (ja) ジヒドロアルテミシニンを含む舌下スプレー用製剤
KR101466617B1 (ko) 오메가-3 지방산 및 HMG-CoA 환원효소 억제제를 포함하는 안정성이 증가된 경구용 복합 제제
GB2469754A (en) Sub-lingual drug delivery system using a neutral oil
JP2011526621A (ja) 経口バイオアベイラビリティが増大したフェノフィブラート製剤
CN110996926A (zh) 用于将亲脂性化合物递送进入和/或穿过皮肤的药物膜组合物
RU2015128028A (ru) Длинноцепочечные липосбалансированные сложные эфиры тестостерона для пероральной доставки
KR101519887B1 (ko) 고지혈증치료제 및 오메가-3 지방산을 함유하는 복합제제
TH82344A (th) เลอร์คานิไดปีนแคปซูล
IT1293835B1 (it) Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
TH82344B (th) เลอร์คานิไดปีนแคปซูล
JP2005075804A (ja) メナテトレノン含有医薬組成物